Cholestyramine ezetimibe

Which of the following best describes the mechanism of action for evolocumab?

1: Decreased degradation of LDL receptors
2: Decreased hepatic production of VLDL
3: Decreased hepatic uptake of LDL
4: Prevention of absorption of dietary cholesterol